日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab and chemotherapy in high-risk, early-stage, ER(+)/HER2(-) breast cancer: a randomized phase 3 trial

帕博利珠单抗联合化疗治疗高危早期ER(+)/HER2(-)乳腺癌:一项随机3期试验

Cardoso, Fatima; O'Shaughnessy, Joyce; Liu, Zhenzhen; McArthur, Heather; Schmid, Peter; Cortes, Javier; Harbeck, Nadia; Telli, Melinda L; Cescon, David W; Fasching, Peter A; Shao, Zhimin; Loirat, Delphine; Park, Yeon Hee; Fernandez, Manuel Gonzalez; Rubovszky, Gábor; Spring, Laura; Im, Seock-Ah; Hui, Rina; Takano, Toshimi; André, Fabrice; Yasojima, Hiroyuki; Ding, Yu; Jia, Liyi; Karantza, Vassiliki; Tryfonidis, Konstantinos; Bardia, Aditya

Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers

MINDACT研究中,ER阳性、HER2阴性的小型乳腺癌患者接受全身治疗的益处

Hilbers, Florentine S; Poncet, Coralie; Tryfonidis, Konstantinos; Viale, Giuseppe; Delaloge, Suzette; Pierga, Jean-Yves; Brain, Etienne G C; Rubio, Isabel T; Thompson, Alastair M; Rutgers, Emiel J T; Piccart, Martine J; van 't Veer, Laura J; Cardoso, Fatima

Immunotherapy for hormone receptor‒positive HER2-negative breast cancer

激素受体阳性HER2阴性乳腺癌的免疫疗法

Cardoso, Fatima; Hirshfield, Kim M; Kraynyak, Kimberly A; Tryfonidis, Konstantinos; Bardia, Aditya

A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers

帕博利珠单抗免疫疗法治疗乳腺癌和妇科癌症的临床、人文和经济价值的叙述性综述

Monberg, Matthew J; Keefe, Steve; Karantza, Vassiliki; Tryfonidis, Konstantinos; Toker, Sarper; Mejia, Jaime; Orlowski, Robert; Haiderali, Amin; Prabhu, Vimalanand S; Aktan, Gursel

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

帕博利珠单抗联合化疗后序贯帕博利珠单抗治疗早期三阴性乳腺癌患者:一项随机临床试验的二次分析

Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study

尼拉帕尼治疗携带 BRCA1 和 BRCA2 胚系突变的晚期乳腺癌:EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO 研究

Turner, Nicholas C; Balmaña, Judith; Poncet, Coralie; Goulioti, Theodora; Tryfonidis, Konstantinos; Honkoop, Aafke H; Zoppoli, Gabriele; Razis, Evangelia; Johannsson, Oskar T; Colleoni, Marco; Tutt, Andrew N; Audeh, William; Ignatiadis, Michail; Mailliez, Audrey; Trédan, Olivier; Musolino, Antonino; Vuylsteke, Peter; Juan-Fita, Maria Jose; Macpherson, Iain R J; Kaufman, Bella; Manso, Luis; Goldstein, Lori J; Ellard, Susan L; Láng, István; Jen, Kai Yu; Adam, Virginie; Litière, Saskia; Erban, John; Cameron, David A

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial

EORTC 10041/BIG 3-04 MINDACT III期试验:早期高临床和/或基因组风险乳腺癌患者接受标准蒽环类药物治疗与多西他赛-卡培他滨治疗的比较

Delaloge, Suzette; Piccart, Martine; Rutgers, Emiel; Litière, Saskia; van 't Veer, Laura J; van den Berkmortel, Franchette; Brain, Etienne; Dudek-Peric, Aleksandra; Gil-Gil, Miguel; Gomez, Patricia; Hilbers, Florentine S; Khalil, Zaman; Knox, Susan; Kuemmel, Sherko; Kunz, Georg; Lesur, Anne; Pierga, Jean-Yves; Ravdin, Peter; Rubio, Isabel T; Saghatchian, Mahasti; Smilde, Tineke J; Thompson, Alastair M; Viale, Giuseppe; Zoppoli, Gabriele; Vuylsteke, Peter; Tryfonidis, Konstantinos; Poncet, Coralie; Bogaerts, Jan; Cardoso, Fatima

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

男性乳腺癌的特征:EORTC 10085/TBCRC/BIG/NABCG国际男性乳腺癌项目的结果

Cardoso, F; Bartlett, J M S; Slaets, L; van Deurzen, C H M; van Leeuwen-Stok, E; Porter, P; Linderholm, B; Hedenfalk, I; Schröder, C; Martens, J; Bayani, J; van Asperen, C; Murray, M; Hudis, C; Middleton, L; Vermeij, J; Punie, K; Fraser, J; Nowaczyk, M; Rubio, I T; Aebi, S; Kelly, C; Ruddy, K J; Winer, E; Nilsson, C; Lago, L Dal; Korde, L; Benstead, K; Bogler, O; Goulioti, T; Peric, A; Litière, S; Aalders, K C; Poncet, C; Tryfonidis, K; Giordano, S H

The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches

乳腺癌治疗的过去与未来——从纸莎草文献到个体化治疗方法

Ades, Felipe; Tryfonidis, Konstantinos; Zardavas, Dimitrios

The European Organization for Research and Treatment of Cancer perspective on designing clinical trials with immune therapeutics

欧洲癌症研究与治疗组织关于设计免疫疗法临床试验的观点

Menis, Jessica; Litière, Saskia; Tryfonidis, Konstantinos; Golfinopoulos, Vassilis